Search filters

List of works by Yuankai Shi

Characteristics and Management of TP53-Mutated Diffuse Large B-Cell Lymphoma Patients

scientific article published on 10 November 2020

Clinicopathologic characteristics and outcome of patients with different EGFR mutations

scientific article published on 11 October 2018

Current management of chemotherapy-induced neutropenia in adults: key points and new challenges: Committee of Neoplastic Supportive-Care (CONS), China Anti-Cancer Association Committee of Clinical Chemotherapy, China Anti-Cancer Association

scientific article published on 01 November 2020

Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study.

scientific article published on 20 January 2018

Low CCL19 expression is associated with adverse clinical outcomes for follicular lymphoma patients treated with chemoimmunotherapy

scientific article published on 20 September 2021

Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303

scientific article published on 21 January 2019

Pretreatment body mass index and clinical outcomes in cancer patients following immune checkpoint inhibitors: a systematic review and meta-analysis

scientific article published on 04 August 2020

Prognostic significance of baseline neutrophil–lymphocyte ratio in patients with non-small-cell lung cancer: a pooled analysis of open phase III clinical trial data

scientific article published in 2022

Tracking longitudinal genetic changes of circulating tumor DNA (ctDNA) in advanced Lung adenocarcinoma treated with chemotherapy

scientific article published on 10 October 2019